Iga Nephropathy
📧 Sign up to get email alerts when something new happens for Iga Nephropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
Clinical trial RENAL AID from The Rogosin Institute is investigating novel analytes linked to autoimmune, inflammatory, and diabetic nephrop…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Correlation of Microbiome and Metabonomics With IgA Nephropathy
A clinical trial evaluating the relationship between the gut microbiome, metabonomics, and IgA nephropathy is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: A Clinical Research on the Use of Fecal Bacteria Transplantation for Treatment of IgA Nephropathy [NA]
The document reports a completed clinical trial assessing fecal microbiota transplantation for IgA nephropathy, sponsored by Shanxi Provinci…
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria [Phase 3]
A Phase 3 clinical trial evaluating SC0062 capsule for IgA nephropathy with proteinuria is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: TESTING -ON Post-Trial ObservatioNal Cohort Study
A post-trial observational cohort study named TESTING-ON, sponsored by The George Institute, is currently recruiting to observe outcomes in …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: A Study of SGB-9768 in Patients with Complement-mediated Kidney Diseases [Phase 2]
A Phase 2 clinical trial of SGB-9768 for complement-mediated kidney diseases, including IgA nephropathy and C3 glomerulopathy, has not yet s…
-
CLINICAL_TRIALS research · 2025-01-14Clinical Trial Update: A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases [Phase 1, Phase 2]
SCTC21C is being studied for plasma cell–driven autoimmune diseases, including IgA nephropathy, in Phase 1/2 trials that are not yet recruit…
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: A Study of Probiotics in IgA Nephropathy [NA]
A clinical trial is evaluating a probiotic preparation in IgA nephropathy. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease [Phase 2]
This clinical trial update indicates that SC0062 is being investigated in a Phase 2 study for chronic kidney disease, including diabetic kid…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Raman Spectroscopy Diagnosis of Kidney Diseases
This update describes an ongoing clinical trial evaluating Raman spectroscopy as a diagnostic tool for kidney diseases, including IgA nephro…
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy [Phase 2]
Phase 2 study evaluating the safety and activity of Sparsentan in incident patients with immunoglobulin A nephropathy; the trial is currentl…
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients [EARLY_Phase 1]
Early-phase (Phase 1) trial update for IM19 CAR-T cell therapy in IgA nephropathy and membranous nephropathy; the study is not yet recruitin…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Interest of Follicular Helper Lymphocytes / Regulatory Follicular Helper Lymphocytes Ratio in IgA Nephropathy [NA]
A clinical trial investigating the role of follicular helper T cells and the regulatory follicular helper T cell to T cell ratio in IgA neph…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN) [Phase 2]
Phase 2 clinical trial to evaluate the efficacy and safety of MY008211A in subjects with immunoglobulin A nephropathy (IgAN). The study is c…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients with Primary IgAN [Phase 2]
This clinical trial update indicates that a Phase II study of HSK39297 tablet for primary IgA nephropathy is currently recruiting.
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Clinical Study of CM338 in the Treatment of Immunoglobulin A Nephropathy [Phase 2]
A Phase 2 clinical study evaluating CM338 for IgA nephropathy is currently recruiting.
-
CLINICAL_TRIALS research · 2024-10-10Clinical Trial Update: A Study of the Effect and Safety of HS-10390 in the Treatment of Patients with Primary IgA Nephropathy [Phase 2]
A Phase 2 clinical trial update evaluating the efficacy and safety of HS-10390 for primary IgA nephropathy; the study is currently not yet r…
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects [Phase 1]
First-in-human Phase 1 trial to evaluate safety, tolerability, and pharmacology of HS-10390 in healthy subjects; the study lists IgA nephrop…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD [Phase 2, Phase 3]
Clinical trial update describes a Chinese medicine Yi-Qi-Qing-Jie Herbal Compound combined with immunosuppressants being studied in IgA neph…
-
CLINICAL_TRIALS research · 2024-08-30Clinical Trial Update: Effect of Finerenone in IgA Nephropathy [Phase 3]
Phase 3 clinical trial evaluating finerenone for IgA nephropathy is listed as not yet recruiting, with Zhejiang University as sponsor.
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: The Effect of OSA on Severity and Prognosis of Patients With IgAN
A protocol to study how obstructive sleep apnea affects the severity and prognosis of IgA nephropathy; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-05-28Clinical Trial Update: The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA)
This entry reports the ongoing status of the Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA), sponsored by Ruijin Hospital,…
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD [Phase 3]
A Phase 3 clinical trial evaluating the efficacy of immunosuppressive therapy for IgA nephropathy in patients with stage 3 or 4 chronic kidn…
-
CLINICAL_TRIALS research · 2019-02-08Clinical Trial Update: Effect of Immunosuppression in IgA Nephropathy [Phase 4]
A Phase 4 clinical trial from Yonsei University is evaluating the effects of immunosuppression in biopsy-proven IgA nephropathy, with the cu…
-
CLINICAL_TRIALS research · 2017-07-14Clinical Trial Update: Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy [Phase 4]
This clinical trial update describes a Phase 4 study evaluating prednisone plus cyclophosphamide for advanced-stage IgA nephropathy. The sta…